Acadian Asset Management
TYRA icon

Acadian Asset Management’s Tyra Biosciences TYRA Stock Holding History

Acadian Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92K Buy
+2,906
New +$96.1K ﹤0.01% 1768
2024
Q4 		– Sell
-848
Closed -$19K – 2176
2024
Q3 		$19K Buy
+848
New +$17.8K ﹤0.01% 1985

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Acadian Asset Management's TYRA Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 2,906 shares worth $92K. The stake represents ﹤0.01% of the portfolio and ranks #1768 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in TYRA as recently as Q3 2024.

Acadian Asset Management first reported a position in TYRA in Q3 2024 and has held it in 2 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Acadian Asset Management held 2,906 shares of Tyra Biosciences worth $92K as of Q2 2026.
  • Tyra Biosciences was a new Acadian Asset Management position in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1768 holding.
  • Acadian Asset Management first reported a position in Tyra Biosciences in Q3 2024 and has held it in 2 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.